2022
DOI: 10.1159/000524718
|View full text |Cite
|
Sign up to set email alerts
|

miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages

Abstract: <b><i>Objective:</i></b> Asthma is a common inflammatory respiratory disease with increasing incidence worldwide. This study aimed to investigate the mechanism of miR-146a-5p in reducing allergic airway inflammation by inhibiting NLRP3 inflammasome activation in macrophages. <b><i>Methods:</i></b> Allergic mouse models were established by ovalbumin stimulation, and mice were treated with miR-146a-5p agomir and oe-TIRAP 3 h before OVA stimulation. The pathological… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 45 publications
1
10
0
Order By: Relevance
“…Notably, miR-146a-5p-EV treatment exhibited more inhibitory effects on airway inflammation ( Figure 7C ), goblet cell hyperplasia ( Figure 7D ), and collagen fiber content ( Figure 7E ) in chronic asthma mice. In addition, the downstream effector of miR-146a-5p, including TNF receptor-associated factor 6 (TRAF6) ( 35 ) and TIR domain-containing adaptor protein (TIRAP) ( 36 ), which are related to airway epithelial cell injury and airway inflammatory response in asthma, were decreased ( Figure 7F ).…”
Section: Resultsmentioning
confidence: 99%
“…Notably, miR-146a-5p-EV treatment exhibited more inhibitory effects on airway inflammation ( Figure 7C ), goblet cell hyperplasia ( Figure 7D ), and collagen fiber content ( Figure 7E ) in chronic asthma mice. In addition, the downstream effector of miR-146a-5p, including TNF receptor-associated factor 6 (TRAF6) ( 35 ) and TIR domain-containing adaptor protein (TIRAP) ( 36 ), which are related to airway epithelial cell injury and airway inflammatory response in asthma, were decreased ( Figure 7F ).…”
Section: Resultsmentioning
confidence: 99%
“…The activation of NLRP3 inflammasome in COPD can be attributed to noxious particles, such as cigarette smoke and PM2.5 5 and such activation may be present in macrophages 44 . NLRP3 inflammasome effectors, IL‐1β and IL‐18, are correlated with COPD‐like symptoms and the disease severity 45 .…”
Section: Discussionmentioning
confidence: 99%
“…The activation of NLRP3 inflammasome in COPD can be attributed to noxious particles, such as cigarette smoke and PM2.5 5 and such activation may be present in macrophages. 44 NLRP3 inflammasome effectors, IL‐1β and IL‐18, are correlated with COPD‐like symptoms and the disease severity. 45 Moreover, corticosteroids alleviate LPS‐induced inflammation and lung injury by blocking the activation of NLRP3 inflammasome, 46 highlighting that NLRP3 inflammasome can be a drug target for COPD treatment and involves the pathogenesis of COPD, particularly those induced by infection.…”
Section: Discussionmentioning
confidence: 99%
“…In mice, infection by B. malayi induces overexpression of mmu-miR-125b-5p, mmu-miR-146a-5p, and mmu-miR-378-3p in macrophages [ 160 ] ( Figure 3 B). These miRNAs activate macrophages, inflammatory response, and cell–cell communication [ 160 , 161 , 162 ]. For example, mmu-miR-125b-5p is involved in morphological changes during macrophage activation, increasing the expression of co-stimulatory molecules (such as CD80) and INF-γ secretion through the suppression of IFN regulatory factor 4 (IRF4) [ 161 ].…”
Section: Mirna In Brugia Malayi –Host Interactionmentioning
confidence: 99%